Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 2, 2010, Pages 376-382

  Yokokawa, Junko ^a   Saito, Hironobu ^a   Kanno, Yukiko ^a   Honma, Fumiko ^a   Monoe, Kyoko ^a   Sakamoto, Natsumi ^a   Abe, Kazumichi ^a   Takahashi, Atsushi ^a   Yokokawa, Hirohide ^a   Ohira, Hiromasa ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune hepatitis (AIH); Immunosuppressive therapy; Long term outcomes; PBC AIH overlap; Primary biliary cirrhosis (PBC)

Indexed keywords

PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; BRAIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG FATALITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VARICOSIS;

EID: 76149100217     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06018.x     Document Type: Article

References (28)

1. Saito H, Rai T, Takahashi A et al. Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap. Fukushima J. Med. Sci. 2006 52 : 71 7.
2. Czaja AJ. The variant forms of autoimmune hepatitis. Ann. Intern. Med. 1996 125 : 588 598.
3. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998 28 : 360 365.
4. Chazouillères O, Wendum D, Serfaty L et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998 28 : 296 301.
5. Talwalkar JA, Keach JC, Angulo P et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am. J. Gastroenterol. 2002 97 : 1191 1197.
6. Joshi S, Cauch-Dudek K, Wanless IR et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002 35 : 409 413.
7. Yamamoto K, Terada R, Okamoto R et al. A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J. Gastroenterol. 2003 38 : 52 9.
8. Lohse AW, Meyer zum Büschenfelde KH, Franz B et al. Characterization of the overlap syndrome of primary biliary cirrhosis and auto-immune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999 29 : 1078 1084.
9. Alvarez F, Berg PA, Bianchi FB et al. International auto-immune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999 31 : 929 938.
10. Hulburt KJ, McMahon BJ, Deubner H et al. Prevalence of autoimmune liver disease in Alaska Natives. Am. J. Gastroenterol. 2002 97 : 2402 2407.
11. Muratoti L, Cassani F, Pappas G et al. The hepatitic/cholestatic ?overlap? syndrome: an Italian experience. Autoimmunity 2002 35 : 565 568.
12. Gheorghe L, Iacob S, Gheorghe C et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur. J. Gastroenterol. Hepatol. 2004 16 : 585 592.
13. Silveira MG, Talwalkar JA, Angulo P et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am. J. Gastroenterol. 2007 102 : 1244 1250.
14. Poupon RE, Lindor KD, Cauch-Dudek K et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997 113 : 884 890.
15. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q. J. Med. 1971 40 : 159 185.
16. Heathcote EJ. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am. J. Gastroenterol. 2002 97 : 1090 1092.
17. Chazouillères O, Wendum D, Serfaty L et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J. Hepatol. 2006 44 : 400 406.
18. Gunsar F, Akarca US, Ersöz G et al. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune overlap syndrome. Hepatogastroenterology 2002 49 : 1195 1200.
19. Heurgué A, Vitry F, Diebold MD et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol. Clin. Biol. 2007 31 : 17 25.
20. Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008 48 : 169 176.
21. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 293.
22. Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig. Dis. Sci. 1996 41 : 305 314.
23. Villamil AG, Welz G, Bandi JC et al. Overlap syndrome PBC/AIH: prevalence, long term evolution and prognostic factors (abstract). J. Hepatol. 2004 40 : 163.
24. Czaja AJ, Carpenter H. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001 34 : 659 665.
25. Degott C, Zafrani ES, Callard P et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999 29 : 1007 1012.
26. Doniach D, Walker JG. A unified concept of autoimmune hepatitis. Lancet 1969 1 : 813 815.
27. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993 18 : 10 15.
28. Colombato LA, Alvarez F, Côté J et al. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994 107 : 1839 1843.